Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects

Yoshifumi Saisho, Taro Maruyama, Hiroshi Hirose, Takao Saruta

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: Type 2 diabetes (T2DM) is characterized by increased proinsulin-to-insulin ratio (P/I ratio), increased glycation and oxidative stress, and β-cell dysfunction. Previous reports implicated that increased P/I ratio, glycation and oxidative stress constitute markers of β-cell dysfunction in T2DM. However, its clinical relevance remains to be elucidated. Therefore, in the present study we investigated the relationship between the P/I ratio, glycation and oxidative stress markers in patients with T2DM, using newly developed intact chemiluminescent immunoassay for proinsulin. Methods: Fasting intact proinsulin, insulin, advanced glycation endproducts (AGEs), pentosidine, lipid peroxide and urine 8-isoprostane as well as other metabolic parameters were measured in 64 T2DM subjects. Results: Using univariate analysis, P/I ratio showed significant positive correlations with plasma glucose (r = 0.465), HbA1c (r = 0.434) and AGEs (r = 0.282), and significant negative correlations with insulin (r = -0.330) and HOMA-β (r = -0.520) even after adjustment for age, sex, duration of diabetes, family history of diabetes, use of sulfonylureas, smoking and body mass index. Additionally, stepwise multiple regression analysis revealed that HOMA-β, HbA1c and AGEs were independently and significantly correlated with P/I ratio. Conclusion: These findings suggest that not only hyperglycemia per se but also glycation is involved in β-cell dysfunction in T2DM subjects.

Original languageEnglish
Pages (from-to)182-188
Number of pages7
JournalDiabetes Research and Clinical Practice
Volume78
Issue number2
DOIs
Publication statusPublished - 2007 Nov

Fingerprint

Proinsulin
Insulin
8-epi-prostaglandin F2alpha
Oxidative Stress
Lipid Peroxides
Immunoassay
Hyperglycemia
Type 2 Diabetes Mellitus
Fasting
Body Mass Index
Smoking
Regression Analysis
Urine
Glucose

Keywords

  • Advanced glycation endproducts
  • Oxidative stress marker
  • Proinsulin
  • Proinsulin-to-insulin ratio
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects. / Saisho, Yoshifumi; Maruyama, Taro; Hirose, Hiroshi; Saruta, Takao.

In: Diabetes Research and Clinical Practice, Vol. 78, No. 2, 11.2007, p. 182-188.

Research output: Contribution to journalArticle

@article{74d634e7618246f28953bf23f5cc4c9f,
title = "Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects",
abstract = "Objective: Type 2 diabetes (T2DM) is characterized by increased proinsulin-to-insulin ratio (P/I ratio), increased glycation and oxidative stress, and β-cell dysfunction. Previous reports implicated that increased P/I ratio, glycation and oxidative stress constitute markers of β-cell dysfunction in T2DM. However, its clinical relevance remains to be elucidated. Therefore, in the present study we investigated the relationship between the P/I ratio, glycation and oxidative stress markers in patients with T2DM, using newly developed intact chemiluminescent immunoassay for proinsulin. Methods: Fasting intact proinsulin, insulin, advanced glycation endproducts (AGEs), pentosidine, lipid peroxide and urine 8-isoprostane as well as other metabolic parameters were measured in 64 T2DM subjects. Results: Using univariate analysis, P/I ratio showed significant positive correlations with plasma glucose (r = 0.465), HbA1c (r = 0.434) and AGEs (r = 0.282), and significant negative correlations with insulin (r = -0.330) and HOMA-β (r = -0.520) even after adjustment for age, sex, duration of diabetes, family history of diabetes, use of sulfonylureas, smoking and body mass index. Additionally, stepwise multiple regression analysis revealed that HOMA-β, HbA1c and AGEs were independently and significantly correlated with P/I ratio. Conclusion: These findings suggest that not only hyperglycemia per se but also glycation is involved in β-cell dysfunction in T2DM subjects.",
keywords = "Advanced glycation endproducts, Oxidative stress marker, Proinsulin, Proinsulin-to-insulin ratio, Type 2 diabetes",
author = "Yoshifumi Saisho and Taro Maruyama and Hiroshi Hirose and Takao Saruta",
year = "2007",
month = "11",
doi = "10.1016/j.diabres.2007.03.014",
language = "English",
volume = "78",
pages = "182--188",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects

AU - Saisho, Yoshifumi

AU - Maruyama, Taro

AU - Hirose, Hiroshi

AU - Saruta, Takao

PY - 2007/11

Y1 - 2007/11

N2 - Objective: Type 2 diabetes (T2DM) is characterized by increased proinsulin-to-insulin ratio (P/I ratio), increased glycation and oxidative stress, and β-cell dysfunction. Previous reports implicated that increased P/I ratio, glycation and oxidative stress constitute markers of β-cell dysfunction in T2DM. However, its clinical relevance remains to be elucidated. Therefore, in the present study we investigated the relationship between the P/I ratio, glycation and oxidative stress markers in patients with T2DM, using newly developed intact chemiluminescent immunoassay for proinsulin. Methods: Fasting intact proinsulin, insulin, advanced glycation endproducts (AGEs), pentosidine, lipid peroxide and urine 8-isoprostane as well as other metabolic parameters were measured in 64 T2DM subjects. Results: Using univariate analysis, P/I ratio showed significant positive correlations with plasma glucose (r = 0.465), HbA1c (r = 0.434) and AGEs (r = 0.282), and significant negative correlations with insulin (r = -0.330) and HOMA-β (r = -0.520) even after adjustment for age, sex, duration of diabetes, family history of diabetes, use of sulfonylureas, smoking and body mass index. Additionally, stepwise multiple regression analysis revealed that HOMA-β, HbA1c and AGEs were independently and significantly correlated with P/I ratio. Conclusion: These findings suggest that not only hyperglycemia per se but also glycation is involved in β-cell dysfunction in T2DM subjects.

AB - Objective: Type 2 diabetes (T2DM) is characterized by increased proinsulin-to-insulin ratio (P/I ratio), increased glycation and oxidative stress, and β-cell dysfunction. Previous reports implicated that increased P/I ratio, glycation and oxidative stress constitute markers of β-cell dysfunction in T2DM. However, its clinical relevance remains to be elucidated. Therefore, in the present study we investigated the relationship between the P/I ratio, glycation and oxidative stress markers in patients with T2DM, using newly developed intact chemiluminescent immunoassay for proinsulin. Methods: Fasting intact proinsulin, insulin, advanced glycation endproducts (AGEs), pentosidine, lipid peroxide and urine 8-isoprostane as well as other metabolic parameters were measured in 64 T2DM subjects. Results: Using univariate analysis, P/I ratio showed significant positive correlations with plasma glucose (r = 0.465), HbA1c (r = 0.434) and AGEs (r = 0.282), and significant negative correlations with insulin (r = -0.330) and HOMA-β (r = -0.520) even after adjustment for age, sex, duration of diabetes, family history of diabetes, use of sulfonylureas, smoking and body mass index. Additionally, stepwise multiple regression analysis revealed that HOMA-β, HbA1c and AGEs were independently and significantly correlated with P/I ratio. Conclusion: These findings suggest that not only hyperglycemia per se but also glycation is involved in β-cell dysfunction in T2DM subjects.

KW - Advanced glycation endproducts

KW - Oxidative stress marker

KW - Proinsulin

KW - Proinsulin-to-insulin ratio

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=34648814400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648814400&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2007.03.014

DO - 10.1016/j.diabres.2007.03.014

M3 - Article

VL - 78

SP - 182

EP - 188

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 2

ER -